Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Ecotoxicology and Environmental Safety|June 1, 1993
Validation of some extrapolation methods with toxicity data derived from multiple species experimentsP C Okkerman, E J van de Plassche, H J Emans, et al.
Ecotoxicology and Environmental Safety|April 1, 1991
Ecotoxicological effects assessment: a comparison of several extrapolation proceduresP C Okkerman, E J vd Plassche, W Slooff, et al.
Nature|May 15, 1997
Regulation of serotonin-2C receptor G-protein coupling by RNA editingC M Burns, H Chu, S M Rueter, et al.
Regulatory Toxicology and Pharmacology : RTP|June 1, 1985
Toxicity, biodegradability, and accumulation of a number of Cl/N-containing compounds for classification and establishing water quality criteriaJ H Canton, W Slooff, H J Kool, et al.
Journal of Medicinal Chemistry|September 29, 1995
Characterization of potent and selective antagonists at postsynaptic 5-HT1A receptors in a series of N4-substituted arylpiperazinesJ L Peglion, H Canton, K Bervoets, et al.
Molecular Pharmacology|October 1, 1996
Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicingH Canton, R B Emeson, E L Barker, et al.
European Journal of Pharmacology|January 5, 1993
S 15535: a highly selective benzodioxopiperazine 5-HT1A receptor ligand which acts as an agonist and an antagonist at presynaptic and postsynaptic sites respectivelyM J Millan, J M Rivet, H Canton, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1994
Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonistsM J Millan, H Canton, A Gobert, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1992
S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptorsM J Millan, J M Rivet, H Canton, et al.
Pageof 3